Filtricine

About:

Filtricine provides new solution to cancer care via Targeted Nutrients Deprivation.

Twitter/X: filtricine

Top Investors: IndieBio, SOSV, True Ventures, Sand Hill Angels, Boutique Venture Partners

Description:

Filtricine, Inc. is a venture-backed, clinical stage biotech company based in Santa Clara, CA. We are developing a nutrient modulation platform which can identify metabolic vulnerabilities in cancers and exploit those vulnerabilities without the use of drugs.

Total Funding Amount:

$5.25M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Santa Clara, California, United States

Founded Date:

2017-09-06

Contact Email:

info(AT)filtricine.com

Founders:

Grace Xiaolu Yang, Xin Wang, Xiyan Li

Number of Employees:

1-10

Last Funding Date:

2022-08-29

IPO Status:

Private

Industries: